In the course of investigations of coronary artery disease in Utah, we identified a family whose proband showed elevated plasma levels of LDL cholesterol. To determine the genetic etiology of the lipoprotein abnormalities, we screened DNA samples for mutations in all 18 exons and the exon-intron boundaries of the low-density lipoprotein (LDL) receptor gene. Novel point mutations were identified in the proband: a T-to-A transversion at nucleotide position 223, causing substitution of Ser for Cvs at codon 54 in exon 3 of the receptor gene. This amino acid replacement would disrupt one of the disulfide bonds necessary for maintenance of the secondary structure of the repeat at the N-terminal of the receptor, prevent correct folding of the receptor, and result in defective intracellular transport of the receptor. (Jpn Heart j 1998; 39: 785-789) 
H ETEROZYGOUS
familial hypercholesterolemia (FH) results from inheritance of a single defective copy of a low-density lipoprotein receptor (LDLR) gene.1) The disease is recognized clinically by striking elevations of LDL cholesterol (about twice the normal range, or>95th percentile) in children as well as adults. Affected families display bimodally distributed LDL cholesterol levels consistent with an autosomal dominant trait. In general, only LDL cholesterol levels are elevated in FH; elevated triglycerides or other lipid abnormalities may bring into question the diagnosis of FH and may suggest other inherited primary lipid disorders such as familial combined hyperlipidemia, or secondary lipid disorders.
The LDLR gene is large and structurally complex; it spans 45 kb of the human genome and consists of 18 exons and 17 introns.2) No mutational "hotspot" has been identified; in fact, specific mutations rarely recur either among unrelated Caucasians or among families residing in mainland Japan.3,4) The LDLR mutations have been classified into the following five classes on the basis of biosynthetic and functional studies of fibroblasts derived from FH patients; null alleles (class 1 mutations), transport-defective alleles (class 2 mutations), bindingdefective alleles (class 3 mutations), internalization-defective alleles (class 4 mutations), and recycling-deficient alleles (class 5 mutations).3-5) We describe here the identification of a novel mutation of the LDLR gene in a hypercholesterolemic kindred in Utah, that would result in defective intracellular transport of the LDL receptor. lowed by the Cardiovascular Genetics Research Clinic of the University of Utah. Pedigree analysis of the proband's family showed a Mendelian mode of inheritance of the mutant allele. Plasma lipoprotein level of the proband at age 27 was total cholesterol 389mg/dl, triglyceride 135mg/dl, HDL cholesterol 58mg/dl, and LDL cholesterol 298mg/dl. Mutation screening of the LDL receptor gene in the proband's genomic DNA identified an aberrant SSCP pattern in the PCR amplification product of exon 3 (Figure, A) . Direct sequencing on both strands revealed heterozygosity for a T-to-A transversion at nucleotide position 223 of the LDL receptor cDNA (Yamamoto et al. 1984 ). This transversion would substitute serine for cysteine at codon 54 (C54S) (Figure, C) .
MATERIALS AND METHODS

Patients
The mutation abolishes a PbuII site, and therefore the absence of this site, diagnostic for the C54S mutation, can be assayed in a restriction fragment length polymorphism (RFLP) analysis. The normal allele was cleavable by PbuII and digestion produced 112 bp and 54 bp fragments. The C54S mutant allele was uncleavable by PvuII and digestion produced a 166 bp band. Figure, B shows that the proband was heterozygous for the mutant and normal alleles. C54S was the only sequence variation detected in the entire coding and splice-site consensus sequences of the LDL receptor gene of the proband. The proband's mother and her maternal grandparents were negative for the C54S mutation. The proband's father is deceased. The proband has no siblings or children. A group of 75 FH patients from Utah was screened for the presence of the C54S mutation. No additional index case was identified. This variant was not found in 96 control, normolipidemic individuals. Functionally, LDLR mutations were classified into five classes on the basis of studies that involved fibroblasts derived from FH patients.3-5) Class 2 alleles encode proteins that are blocked either completely or partially in transport between the endoplasmic reticulum and the Golgi apparatus. We observed a substitution of serine for cysteine at codon 54. Cys54 is the second critical cysteine of the second repeat of the ligand binding domain that consists of seven repeats of 40 amino acids; each repeat contains six cysteine residues that form three intra repeat disulfide bonds.2) Thus, C54S mutation belongs to the transport-defective alleles (class 2 mutation), since disruption of one of the three disulfide bonds required for maintaining the secondary structure of the repeat would prevent correct folding of the receptor during synthesis and transport in the endoplasmic reticulum.3,4) Previously, several other missense mutants occurring in the seven repeats of the ligand binding domain encoded by exon 2 through 6 have been functionally characterized.4) Since most of them encoded receptors that were blocked in transport between the endoplasmic reticulum and the Golgi apparatus (class 2; transport-defective alleles), we postulate that the C54S mutation reported here would cause the same class of deficiency on account of its location. Other possibilities cannot be ruled out, however, until proper functional tests are conducted for this particular mutation. Our study illustrates the feasibility of molecular genetic approaches in strengthening clinical diagnosis)10,11) and invoking appropriate management of young members of families with FH, with a view toward early intervention in cases of predisposition to coronary heart disease.
